Metformin, a drug used to treat diabetes and polycystic ovarian syndrome (PCOS), may increase survival for women with ovarian cancer. A study of 239 women with ovarian cancer divided them into two arms: those with diabetes who were taking metformin and those who did not have diabetes. More women with diabetes lived longer.
Read the abstract of the study here
A research team, led by Dr. Ugo Cavallaro and supported by OCRA’s 2019 Collaborative Research Development Grant, made progress toward improving immunotherapies for ovarian cancer. Dr. Frances R. Balkwill, a … Continued
Leaders in the patient advocacy space came together for a wide-ranging study on the often-overlooked challenges faced by caregivers of cancer patients, with Tracy Moore, LCSW, who serves as Ovarian … Continued
A study published in Nature Cancer details how OCRA-funded research has dramatically expanded the impact of DNA and RNA data in the Cancer Genome Atlas and Cancer Cell Line Encyclopedia, … Continued
Get email updates about research news, action alerts, and ways to join the fight.
